Blockchain Registration Transaction Record

Silo Pharma Closes $2M Public Offering to Advance Novel Therapeutics

Silo Pharma closes $2M public offering to advance novel therapeutics. The offering includes common stock, warrants, and Series A-1 and A-2 warrants. Funds will support R&D for innovative treatments addressing stress-induced psychiatric disorders and chronic pain.

Silo Pharma Closes $2M Public Offering to Advance Novel Therapeutics

This news matters as it highlights Silo Pharma's efforts to develop innovative treatments for underserved conditions. The successful public offering will provide the company with the necessary funds to further their research and development, potentially leading to groundbreaking therapies for psychiatric disorders, chronic pain, and CNS diseases.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x47d3fdd2d76293a9c587b85b7ee8c7183f47050e78ba909f300754e13499d719
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprinturgeaxWE-83d7457e3059ffb3951ec38f8dc7299a